Host Brain Tissue (HBT) is an advanced, biologically based tissue engineering material that is being tested as a potential tissue-engineering scaffold for tissue engineering applications. It has been developed to provide a three-dimensional (3D) scaffold with the properties of mechanical and structural support, quality cell adhesion, and controlled biocompatibility. HBT is composed of a 3D nanostructured polymeric matrix made up of polyethylene glycol (PEG), synthetic polymers, and natural polymers. This scaffold allows for the growth of different cell types, such as neurons and glia, while supporting and maintaining the cellular architecture. Given its 3D structure, HBT offers several advantages compared to other scaffolding materials for tissue engineering. One benefit is its ability to provide a mechanical support for the growing tissue; HBT’s strength enables it to withstand the physical pressures exerted by cellular migration and proliferation. Additionally, HBT's surface architecture allows cells to attach and proliferate faster than other scaffolds. Its size and design can also be tailored to meet specific tissue engineering needs. Another advantage of HBT is its biocompatibility. HBT is safe for use in clinical applications, as it contains no toxic materials. It has been tested in a variety of tissues, such as nerve, bone, cartilage, and muscle, and found to be nontoxic in all cases. Furthermore, due to its compatibility with a variety of cells, HBT provides a semi-permeable structure for cell seeding and nutrient exchange. Finally, HBT's flexibility allows it to be used in difficult to access body cavities, such as the brain or cranial spine. In summary, HBT provides an advanced, biologically based tissue-engineering scaffold that offers several advantages over other scaffolding materials. It provides a three-dimensional structure that allows cell attachment and proliferation, mechanical support for the growing tissue, and biocompatibility for clinical use.
Title : Scalp acupuncture with functional electrical stimulation for the treatment children with autism spectrum disorder
Zhenhuan Liu, Guangzhou University of Chinese Medicine, China
Title : Music therapy combined with acupuncture therapy for children with autism spectrum disorder
Zhenhuan Liu, Guangzhou University of Chinese Medicine, China
Title : Diquat exposure induces brainstem demyelination and encephalopathy via upregulating the mitochondrial calcium uniporter
Weixia Duan, The First Affiliated Hospital of Chongqing Medical and Pharmaceutical College, China
Title : Transcranial direct current stimulation (TDCS) for chronic migraine: a randomized clinical trial with 20 patients.
Milton C R Medeiros, Hospital Santa Casa de Arapongas, Brazil
Title : A computational approach to evaluate the impact of chemical pathways on brain activity on a broad scale.
Rahul Hajare, Sandip University, India
Title :
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation